136 related articles for article (PubMed ID: 24084461)
1. Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis.
Ryabtseva OD; Lukianova NY; Shmurakov YA; Polishchuk LZ; Antipova SV
Exp Oncol; 2013 Sep; 35(3):211-8. PubMed ID: 24084461
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.
Shim HS; Yoon BS; Cho NH
Hum Pathol; 2009 May; 40(5):693-8. PubMed ID: 19157508
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of e-cadherin in epithelial ovarian cancer.
Koensgen D; Freitag C; Klaman I; Dahl E; Mustea A; Chekerov R; Braicu I; Lichtenegger W; Sehouli J
Anticancer Res; 2010 Jul; 30(7):2525-30. PubMed ID: 20682978
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
7. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
[TBL] [Abstract][Full Text] [Related]
8. The potential prognostic value of cathepsin D protein in serous ovarian cancer.
Chai Y; Wu W; Zhou C; Zhou J
Arch Gynecol Obstet; 2012 Aug; 286(2):465-71. PubMed ID: 22476353
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
[TBL] [Abstract][Full Text] [Related]
10. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
[TBL] [Abstract][Full Text] [Related]
11. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary.
Choi CH; Sung CO; Kim HJ; Lee YY; Song SY; Song T; Kim J; Kim TJ; Lee JW; Bae DS; Kim BG
Hum Pathol; 2013 Jun; 44(6):1017-23. PubMed ID: 23290009
[TBL] [Abstract][Full Text] [Related]
13. E-Cadherin and CD44 expression in cervical intraepithelial neoplasia: comparison between HIV-positive and HIV-negative women and correlation with HPV status.
Daraï E; Walker-Combrouze F; Bénifla JL; Hénin D; Feldmann G; Madelenat P; Scoazec JY
Gynecol Oncol; 2000 Jan; 76(1):56-62. PubMed ID: 10620442
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hormonal receptor status of malignant ovarian tumors.
Tkalia IG; Vorobyova LI; Svintsitsky VS; Nespryadko SV; Goncharuk IV; Lukyanova NY; Chekhun VF
Exp Oncol; 2014 Jun; 36(2):125-33. PubMed ID: 24980769
[TBL] [Abstract][Full Text] [Related]
16. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
Wong KK; Lu KH; Malpica A; Bodurka DC; Shvartsman HS; Schmandt RE; Thornton AD; Deavers MT; Silva EG; Gershenson DM
Int J Gynecol Pathol; 2007 Oct; 26(4):404-9. PubMed ID: 17885490
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis.
Dian D; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):437-43. PubMed ID: 20803206
[TBL] [Abstract][Full Text] [Related]
18. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N
Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
[TBL] [Abstract][Full Text] [Related]
19. Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer.
Pietzner K; Woopen H; Richter R; Joens T; Braicu EI; Dimitrova D; Mellstedt H; Darb-Esfahani S; Denkert C; Lindhofer H; Fotopoulou C; Sehouli J
Int J Gynecol Cancer; 2013 Jun; 23(5):797-802. PubMed ID: 23694980
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms.
Cho EY; Choi Y; Chae SW; Sohn JH; Ahn GH
Pathol Int; 2006 Feb; 56(2):62-70. PubMed ID: 16445817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
